Ken Griffin Teva Pharmaceutical Industries LTD Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 3,914,400 shares of TEVA stock, worth $64.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,914,400
Previous 2,309,200
69.51%
Holding current value
$64.4 Million
Previous $41.6 Million
107.33%
% of portfolio
0.02%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding TEVA
# of Institutions
678Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$708 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$641 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$603 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$467 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$448 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...